Navigation Links
LOGICARE Selects M2SYS Biometric Fingerprint Software to Ensure Patient Privacy and Protect Confidential Information
Date:1/22/2008

Leading Healthcare Solutions Provider Integrates Award-Winning Fingerprint

Recognition Solution for HIPAA Compliance, Patient Security, and

Operational Efficiencies

ATLANTA, Jan. 22 /PRNewswire/ -- M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that LOGICARE Corporation has enhanced its OnRecord(TM) healthcare solution for emergency departments and patient educators by integrating M2SYS' Bio-Plugin(TM) fingerprint software. The biometric module is now available to LOGICARE's growing customer base for OnRecord(TM) solutions throughout the United States.

"LOGICARE is using Bio-Plugin(TM) as a part of its vision to help patients maintain their right to privacy and to help our customers conform to HIPAA security regulations," noted Dan McCune, a LOGICARE technical business analyst who is part of the company's product planning efforts. "Bio-Plugin(TM) not only enhances the security of our solutions but also makes it easier for busy users in the Emergency Department to quickly access the data they need to organize and document care. Selecting M2SYS' innovative Bio-Plugin(TM) technology has enabled us to deliver this important feature more rapidly than if we had used a fingerprint SDK. Bio-Plugin(TM) also simplifies our support."

Bio-Plugin(TM) enables software companies to rapidly integrate an enterprise-ready, seamless fingerprint recognition system, including a high-performance 1:N identification engine. Bio-Plugin(TM) eliminates the system dependencies, extensive development, and specialized knowledge of biometric complexities that are inherent to fingerprint SDKs. This enables software companies to remain focused on their core products, while adding a new revenue channel and more value to their customers with an integrated fingerprint authentication module.

"M2SYS is proud of LOGICARE's decision to select our cutting-edge fingerprint technology instead of a b
'/>"/>

SOURCE M2SYS Technology
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. Software Techniques Inc. Selects M2SYS Fingerprint Software to Meet Continuous Growth and Demand for Desktop Biometric Time & Attendance Solutions
2. NIH selects LIAI for major study on allergy molecular causes and possible treatments
3. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
4. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
5. M2SYS Technology Partners with TeraCorp Enterprises to Provide Added Security Within Check Cashing Solution
6. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
7. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
8. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
9. e-Smart(R) Technologies, Inc., Announces Next Generation Superthin Polyimide Flexible Circuit Biometric Super Smart Card(TM) card, the i am(TM) Card.
10. Pixelplus Unveils Its PM1002 as A Practical Biometric Solution for Iris, Facial and Fingerprint Recognition
11. Lockheed Martin Advances Biometrics Portfolio Through Cooperation Agreement With Cognitec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)... , , In an important step toward demystifying the...urodegenerative disease, researchers have created ...ers peptide aggregate using electron microscopy. T...f the National Academy of Sciences, reports that r...ss., and the Leibniz Institut in Jena, Germany, ha...
(Date:5/12/2008)... , Chicago, IL May 12, 2008 There exists much e...ology and medicine and the relationship to religio...& Ethics, Laurie Zoloth takes an approach to medic..., and philosophy to show how acting to change the ...Genetic explanations for how the natural world fun...
(Date:5/12/2008)... , More than 600 million years of evolution has t...llops - down very different physical paths from a ...rs have found that a motor protein, myosin 2, rema..., The discovery suggests that the tiny motor prote... and for humans it may even hold a key to understa...
(Date:5/11/2008)... , Most female frogs dont call; most lack or ha...selects a mate from a chorus of males and then sil...red torrent frog, Odorrana tormota, has a more dir...high-pitched chirp that to the human ear sounds li...ual frog-related findings reported this week in th...
Breaking Biology News(10 mins):Seeing Alzheimer's amyloids 2Religion and the narrative of biological science 2Ancient protein offers clues to killer condition 2Female concave-eared frogs draw mates with ultrasonic calls 2Female concave-eared frogs draw mates with ultrasonic calls 3American Chemical Societys Weekly PressPac Oct 3 2007 709 1American Chemical Societys Weekly PressPac Oct 3 2007 709 2American Chemical Societys Weekly PressPac Oct 3 2007 709 3American Chemical Societys Weekly PressPac Oct 3 2007 709 4American Chemical Societys Weekly PressPac Oct 3 2007 709 5American Chemical Societys Weekly PressPac Oct 3 2007 709 6American Chemical Societys Weekly PressPac Oct 3 2007 709 7American Chemical Societys Weekly PressPac Oct 3 2007 709 8KineMed to Present at the 4th Annual BIO Investor Forum 1112 1KineMed to Present at the 4th Annual BIO Investor Forum 1112 2ADVENTRX Appoints Vice President of Commercialization 1110 1ADVENTRX Appoints Vice President of Commercialization 1110 2ADVENTRX Appoints Vice President of Commercialization 1110 3Green leather is in this season 708 1
...o effect has heated up over the past year as more ...hysiological responses to placebos. A new study ta... a clinical trial, showing a discernible placebo e...b. 1 British Medical Journal. , While researchers...he effectiveness of a new treatment, this trial pi...
...lished in this week,s New England Journal of Medic...ted that it can safely prevent 98 percent of sever...t for 2 million hospital visits and 500,000 pediat...rgest pre-licensure vaccine clinical trials ever c...ern Virginia Medical School investigator demonstra...
...s against the Epstein-Barr virus, the virus that m... to develop multiple sclerosis 15 to 20 years late...ill appear in the June 2006 print issue of Archive... , Researchers have long suspected that external f...is (MS), a chronic autoimmune disease that affects...
...d statins do not appear to reduce the incidence of...ysis of previous studies in the January 4 issue of... reduce the risk of developing cancer, the authors...rticle. "Statins have been studied in numerous la...ed trials for primary and secondary prevention of ...
Other Biology News:All placebos not created alike 2New vaccine for condition that kills 500,000 children a year 2New vaccine for condition that kills 500,000 children a year 3Epstein-Barr virus may be associated with multiple sclerosis 2Statins have neutral effect on risk of cancer 2
(Date:5/12/2008)... - Presentation to be Webcast ...-- Synvista Therapeutics,Inc. (Amex: SYI ) annou...ent,and Chief Executive Officer of Synvista will p... Global Healthcare Conference on Monday, May 19, 2...will be held from May 19-20,2008 at the Le Meridi...
(Date:5/12/2008)... ROCKVILLE, Md., May 12 /-...responded today to the two new patent,infringement... saying that,it believes them, and the earlier cla...baseless., (Logo: http://www.newscom.com/cgi-bin...the counterclaim to their lawsuit, which we filed ...
(Date:5/12/2008)... LAWRENCEVILLE, N.J., May 12 /- Aton...ompany, announced today that it has signed a,distr...mmercialize,CUPRIMINE(R) and SYPRINE(R) in Brazil....izler is working to obtain regulatory approval of ...sential products, and Aton is,committed to making ...
(Date:5/12/2008)... Toronto Stock Exchange Symbol: ...MS Medical Corp (TSX: MS),a leading developer in ...nounced that Mr. Kevin Giese, President and CEO, w...lobal Healthcare Conference in Monte Carlo,Monaco... Time), WHERE: Le Meridien Beach Plaza Hotel, ...
Breaking Biology Technology:Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3Neuralstem Responds to New StemCells, Inc. Lawsuit 2Aton Pharma Announces Distribution Partnership in Brazil 2BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference 2
... , In traditional DNA sequencing systems...ing either endlabeled primers or by the incorporat... Successful sequencing results produced by these t...te quality. DNA containing nicks, breaks, impuriti...erases to dissociate from the primertemplate compl...
... The peroxisome is a cellular organelle tha..., including the beta-oxidation of very long chain ...racterized by impaired, reduced or total absence o...cumulation of VLCFAs, such as tetracosanoic and he...e disorders are characterized by the accumulation ...
... The European Union prohibits the use of ch...producing animals. For this reason a rapid and sen...and quantification of CAP in milk and milk product...ystem. Although many analytical procedures are des... the advantages of high recovery and short analysi...
...ion of nucleotide and nucleoside analogs from Tara...ieved for the first time using liquid chromatograp... ingredients in the herb were characterized using ...nd precursor scans of tandem mass spectrometry. Th...ive ingredients which have anti-Herpes simplex vir...
Other Biology Technology:A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 2A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 3A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders 2A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders 3A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders 4Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS 2Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS 3Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS 4Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS 5Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS 6Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 2Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 3
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B
...art separation system using the asymmetric flow Fi...se integrates easily with Wyatts multi-angle light...star, as well as the Optilab DSP. The combined sys...tions of the particles/molecules separated by the ...
...determining the absolute count of CD34+ cells in h...l blood samples, and leukapheresis samples. These ...d cell count and a total CD45 (leucocyte) cell cou...t progenitor cell enumeration system. Species Rea...
...and, until recently, no readily available affinity...purification. Standard methods for IgM purificatio...they are not effective for removing all of the maj...has developed an easy-to-use affinity matrix and b...
Biology Products: